| Factor Information | |
|---|---|
| Data ID | 2942 |
| Factor | correlation between VEGF and SpO2 in CHD |
| Description | Significant positive correlations in patients with CHD between VEGF and each of PD-ECGF/TP, leptin, age, hemoglobin, pulmonary pressure and PS. and between PD-ECGF/TP and leptin (p < 0.001). Also, significant positive correlations were observed between leptin and each of PD-ECGF/TP and weight. However, a significant negative correlation was observed between VEGF and SpO2 %. |
| Biomarker | YES |
| Classification | Z (combined factor - combined factor) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | correlations in patients with CHD between angiogenic and other factors |
| p Value | <0.001 |
| Conclusion | Significant positive correlations in patients with CHD between VEGF and each of PD-ECGF/TP, leptin, age, hemoglobin, pulmonary pressure and PS. and between PD-ECGF/TP and leptin (p < 0.001). Also, significant positive correlations were observed between leptin and each of PD-ECGF/TP and weight. However, a significant negative correlation was observed between VEGF and SpO2 %. |
| Risk Factor | unrelated |
| CHD Type | |
|---|---|
| ID | 639 |
| CHD Type | isolated CHD |
| CHD Subtype | TOF/TGA/DORV/VSD/PS/PDA/ASD |
| Reference | |
|---|---|
| PMID | 20406482 |
| Year | 2010 |
| Title | Angiogenic biomarkers in children with congenital heart disease: possible implications |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | patients' data | |
| Region | Assiut, Eygpt | |
| Method | Pearson's correlation coefficient | |
| Race | Eygptian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | r=-0.856 | N/A(correlation between VEGF with SpO2 in CHD) |
